NCT03732677 2026-03-13
NIAGARA
AstraZeneca
Phase 3 Active not recruiting
Clinical Trials
9 trialsNCT06960577 2026-02-23
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
AstraZeneca
Phase 3 Recruiting
NCT03682068 2026-02-03
NILE
AstraZeneca
Phase 3 Active not recruiting
NCT02516241 2026-01-28
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
AstraZeneca
Phase 3 Active not recruiting
NCT04960709 2025-12-19
VOLGA
AstraZeneca
Phase 3 Active not recruiting
NCT03528694 2025-11-25
POTOMAC
AstraZeneca
Phase 3 Active not recruiting
NCT05043090 2025-05-08
SAMETA
AstraZeneca
Phase 3 Active not recruiting
NCT04637594 2025-01-15
IMAGINE
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT03288532 2020-09-07
RAMPART
University College, London
Phase 3 Recruiting